OTCPK:ALLQ

Stock Analysis Report

Executive Summary

ALL-Q-TELL Corp., through its subsidiaries, develops integrated solutions in the areas of security, intelligence, and law enforcement for addressing threats to the United States and other its allies nations’ national security.

Snowflake

Fundamentals

Weak fundamentals or lack of information.

Risks

  • ALL-Q-TELL has significant price volatility in the past 3 months.
  • ALL-Q-TELL's last earnings update was 3411 days ago.
  • ALL-Q-TELL is not covered by any analysts.

Share Price & News

How has ALL-Q-TELL's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

ALLQ

-0.04%

US Healthcare

-0.6%

US Market


1 Year Return

n/a

ALLQ

-9.1%

US Healthcare

0.6%

US Market

No trading data on ALLQ.

No trading data on ALLQ.


Share holder returns

ALLQIndustryMarket
7 Day0%-0.04%-0.6%
30 Day0%-0.5%2.2%
90 Day0%-1.6%1.1%
1 Yearn/a-7.7%-9.1%2.9%0.6%
3 Yearn/a29.6%24.3%44.6%35.2%
5 Year-99.0%-99.0%66.1%56.2%61.9%44.2%

Price Volatility Vs. Market

How volatile is ALL-Q-TELL's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is ALL-Q-TELL undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether ALL-Q-TELL is trading at an attractive price based on the cash flow it is expected to produce in the future. But as ALL-Q-TELL has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of ALLQ’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through ALL-Q-TELL regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is ALL-Q-TELL expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

11.0%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as ALL-Q-TELL has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of ALLQ’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access ALL-Q-TELL's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has ALL-Q-TELL performed over the past 5 years?

0.1%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, ALL-Q-TELL has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

  • When a company lacks a financial track record, its management’s track record becomes important. Corporate governance also plays an important role in a young business as board members are seen as highly-experienced leaders to help steer the company into the future. Take a look at ALL-Q-TELL's' management and board experience and expertise to assess their ability to deliver on their strategic promises.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access ALL-Q-TELL's filings and announcements here.
  • Explore strong past performing companies in the Healthcare industry.

Financial Health

How is ALL-Q-TELL's financial position?


In this section we usually analyse ALL-Q-TELL's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. ALL-Q-TELL has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of ALLQ’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when ALL-Q-TELL's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is ALL-Q-TELL's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate ALL-Q-TELL's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate ALL-Q-TELL's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as ALL-Q-TELL has not reported any payouts.

Unable to verify if ALL-Q-TELL's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as ALL-Q-TELL has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of ALL-Q-TELL's salary, the management and board of directors tenure and is there insider trading?

8.3yrs

Average management tenure


CEO

Roy Mers (71yo)

0yrs

Tenure

0

Roy W. Mers serves as Chief Executive Officer of Sleep Holdings Inc. Mr. Mers served as Chief Executive Officer of Regent Technologies Inc. since March, 1997. From May 1996 to March 1997, he served as the  ...


Management Age and Tenure

8.3yrs

Average Tenure

The average tenure for the ALL-Q-TELL management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

12.2yrs

Average Tenure

70yo

Average Age

The average tenure for the ALL-Q-TELL board of directors is over 10 years, this suggests they are a seasoned and experienced board.


Insider Trading

No 3 month insider trading information.


Ownership Breakdown


Management Team

  • Steve Spink

    Vice President of Marketing

    • Tenure: 0yrs
  • Roy Mers (71yo)

    Chief Executive Officer and Director

    • Tenure: 0yrs
  • Thomas Bowers

    Secretary

    • Tenure: 12.6yrs
  • Don Hodge

    Chairman and President

    • Tenure: 0yrs
  • David Dafinoiu

    Chief Operating Officer

    • Tenure: 9.1yrs
  • Michael Starkweather

    Executive Vice President and General Counsel

    • Tenure: 7yrs

Board Members

  • Roy Mers (71yo)

    Chief Executive Officer and Director

    • Tenure: 0yrs
  • Dan Yost (69yo)

    Member of Advisory Board

    • Tenure: 12.2yrs
  • J. Dunn (59yo)

    Member of Advisory Board

    • Tenure: 12.2yrs
  • James Gaines

    Director

    • Tenure: 12.6yrs
  • Thomas Bowers

    Secretary

    • Tenure: 12.6yrs
  • Tim Snodgrass

    Member of Strategic Advisory Board

    • Tenure: 12.2yrs
  • Michael Breus

    Chairman of Clinical Advisory Board

    • Tenure: 12.1yrs
  • George Korkos (86yo)

    Chairman of Business Advisory Board

    • Tenure: 11.4yrs
  • Russell Rosenberg

    Member of Clinical Advisory Board

    • Tenure: 11.3yrs
  • Don Hodge

    Chairman and President

    • Tenure: 0yrs

Company Information

ALL-Q-TELL Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: ALL-Q-TELL Corp.
  • Ticker: ALLQ
  • Exchange: OTCPK
  • Founded:
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$360.000
  • Shares outstanding: 360.97m
  • Website: https://null

Location

  • ALL-Q-TELL Corp.
  • 2974 LBJ Freeway
  • Suite 401
  • Dallas
  • Texas
  • 75234
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ALLQOTCPK (Pink Sheets LLC)YesCommon StockUSUSDJul 2003

Biography

ALL-Q-TELL Corp., through its subsidiaries, develops integrated solutions in the areas of security, intelligence, and law enforcement for addressing threats to the United States and other its allies nation ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/02/21 05:41
End of Day Share Price2018/11/23 00:00
Earnings2009/06/30
Annual Earnings2009/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.